Juzi’s Revenue Soars 57.2% as Innovation and Channel Expansion Pay Off

Juzi closed out 2024 with impressive gains, reporting 57.2% revenue growth and 42.4% profit growth, powered by a surging hero brand lineup and a well-coordinated online-offline strategy.

The company’s leading brand Comfy did the heavy lifting, bringing in over RMB 4.5 billion—a remarkable 62.9% year-on-year increase—while COLLGENE followed with strong momentum and several standout product launches.

From medical-grade recombinant collagen dressings to acne treatment pens and new hydration lines, Juzi showed it’s not just following beauty trends, but shaping them.

Its R&D engine also picked up speed, with over 70 new patents filed and progress made in Class III medical devices—hinting at the company’s future beyond skincare.

With e-commerce channels contributing nearly 65% of total revenue, and offline stores and pharmacy distribution expanding, Juzi is positioning itself as a serious contender in both medical aesthetics and consumer beauty.

Looking into 2025, the focus is clear: double down on innovation, scale flagship products, and bring new brands to life—all while preparing to commercialize the next generation of medical-grade skin solutions.